← Open Payments lookup

ERIN SIMANIC: Open Payments

NPI 1326594045 · LINCOLN, NE. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$2,297 in 153 payments from 14 companies in 2025. Trend: 2023 $871 · 2024 $1,357 · 2025 $2,297

Food & beverage: $2,221Education: $76
CompanyPaymentsAmount
Otsuka America Pharmaceutical, Inc.28$398
ABBVIE INC.30$325
Teva Pharmaceuticals USA, Inc.17$283
Lundbeck LLC10$250
E.R. Squibb & Sons, L.L.C.23$213
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)11$178
Neurocrine BioSciences, Inc.13$176
Janssen Pharmaceuticals, Inc5$175
Alkermes, Inc.6$107
Axsome Therapeutics, Inc.4$64

Products named: REXULTI, VRAYLAR, COBENFY, UZEDY, CAPLYTA, INGREZZA, ABILIFY MAINTENA, SPRAVATO.

Industry payments across NE — which companies pay providers there.